Here, we present an experimental therapy that is effective in breast cancer cells independently of their p53 and ERα status, and confirm the hypothesis that the elevation of E2F1 in the presence of genotoxic stress could represent a valuable therapy against cancers [38]. This evidence concerns the gene TP53 and breast carcinoma.